NMTRQ9 Meters Biopharma Inc

$0.00
$0.00
(0.00%)
Today
Updated: 11:17 AM EDT
Reported EarningsMay 23
Mkt Cap$14.00
Vol5.00
44

Bearish Sentiment

How do you feel about NMTRQ?

About

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of 9 Meters Biopharma Inc?
What is the 52-week high for 9 Meters Biopharma Inc?

Latest NMTRQ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.